REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
12/12/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,966,535
0.25
11,850,489
1.51
(2) Cash-settled derivatives:
11,442,114
1.46
0
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
121,500
0.02
256,000
0.03
TOTAL:
13,530,149
1.73
12,106,489
1.54
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
JPY
Ordinary
Purchase
1,100
3718
Ordinary
Purchase
900
3745.5
Ordinary
Purchase
400
3745.5
Ordinary
Purchase
400
3692.5
Ordinary
Purchase
1,300
3741.5
Ordinary
Purchase
300
3730.5
Ordinary
Purchase
300
3740
Ordinary
Purchase
300
3730
Ordinary
Purchase
1,700
3668
Ordinary
Purchase
1,300
3662
Ordinary
Purchase
1,200
3666
Ordinary
Purchase
3,400
3708
Ordinary
Purchase
500
3667
Ordinary
Purchase
400
3666
Ordinary
Purchase
1,400
3673
Ordinary
Purchase
200
3672
Ordinary
Purchase
500
3677
Ordinary
Purchase
100
3675
Ordinary
Purchase
400
3677
Ordinary
Purchase
200
3715
Ordinary
Purchase
200
3713
Ordinary
Purchase
800
3716
Ordinary
Purchase
1,500
3672
Ordinary
Purchase
700
3672
Ordinary
Purchase
100
3671
Ordinary
Purchase
100
3671
Ordinary
Purchase
200
3674
Ordinary
Purchase
1,500
3675
Ordinary
Purchase
300
3718
Ordinary
Purchase
1,100
3674
Ordinary
Purchase
100
3708
Ordinary
Purchase
600
3672
Ordinary
Purchase
2,600
3738
Ordinary
Purchase
1,500
3681
Ordinary
Purchase
200
3681
Ordinary
Purchase
300
3683
Ordinary
Purchase
700
3729
Ordinary
Purchase
500
3688
Ordinary
Purchase
500
3687
Ordinary
Purchase
800
3685
Ordinary
Purchase
200
3717
Ordinary
Purchase
700
3685
Ordinary
Purchase
500
3680
Ordinary
Purchase
200
3681
Ordinary
Purchase
1,500
3681
Ordinary
Purchase
100
3681
Ordinary
Purchase
100
3678
Ordinary
Purchase
200
3714
Ordinary
Purchase
800
3729
Ordinary
Purchase
1,900
3713
Ordinary
Purchase
200
3716
Ordinary
Purchase
800
3717
Ordinary
Purchase
2,600
3745
Ordinary
Purchase
100
3745
Ordinary
Purchase
700
3728
Ordinary
Purchase
100
3727
Ordinary
Purchase
200
3721
Ordinary
Purchase
300
3746
Ordinary
Purchase
600
3729
Ordinary
Purchase
1,000
3668
Ordinary
Purchase
300
3668
Ordinary
Purchase
800
3668
Ordinary
Purchase
300
3746
Ordinary
Purchase
1,100
3666
Ordinary
Purchase
100
3673
Ordinary
Purchase
100
3676
Ordinary
Purchase
100
3677
Ordinary
Purchase
200
3677
Ordinary
Purchase
1,100
3676
Ordinary
Purchase
200
3680
Ordinary
Purchase
100
3749
Ordinary
Purchase
300
3720
Ordinary
Purchase
1,500
3721
Ordinary
Purchase
100
3719
Ordinary
Purchase
1,100
3723
Ordinary
Purchase
400
3742
Ordinary
Purchase
1,100
3672
Ordinary
Purchase
1,000
3675
Ordinary
Purchase
100
3728
Ordinary
Purchase
1,100
3744
Ordinary
Purchase
1,100
3740
Ordinary
Purchase
200
3715
Ordinary
Purchase
1,100
3721
Ordinary
Purchase
1,100
3726
Ordinary
Purchase
1,100
3721
Ordinary
Purchase
1,100
3731
Ordinary
Purchase
1,100
3744
Ordinary
Purchase
1,100
3741
Ordinary
Purchase
1,100
3744
Ordinary
Purchase
900
3746
Ordinary
Purchase
1,100
3731
Ordinary
Purchase
1,000
3730
Ordinary
Purchase
1,100
3738
Ordinary
Purchase
80,000
3718
Ordinary
Purchase
100
3713
Ordinary
Purchase
100
3746
Ordinary
Purchase
97,600
3718
Ordinary
Purchase
2,600
3718
Ordinary
Purchase
11,400
3718
Ordinary
Purchase
500
3698
Ordinary
Purchase
600
3694
Ordinary
Purchase
300
3694
Ordinary
Purchase
500
3702
Ordinary
Purchase
500
3696
Ordinary
Purchase
500
3695
Ordinary
Purchase
200
3690
Ordinary
Purchase
500
3707
Ordinary
Purchase
500
3702
Ordinary
Purchase
500
3703
Ordinary
Purchase
600
3690
Ordinary
Purchase
200
3694
Ordinary
Purchase
500
3695
Ordinary
Purchase
500
3701
Ordinary
Purchase
100
3704
Ordinary
Purchase
100
3704
Ordinary
Purchase
100
3729
Ordinary
Purchase
200
3742
Ordinary
Purchase
100
3729
Ordinary
Purchase
200
3747
Ordinary
Purchase
100
3717
Ordinary
Purchase
100
3721.5
Ordinary
Purchase
11,000
3718.122136
Ordinary
Sale
97,600
3718
Ordinary
Sale
100
3739
Ordinary
Sale
100
3719.5
Ordinary
Sale
1,100
3670
Ordinary
Sale
1,800
3674.5
Ordinary
Sale
1,200
3672.5
Ordinary
Sale
1,500
3672.5
Ordinary
Sale
200
3726.5
Ordinary
Sale
300
3719
Ordinary
Sale
100
3664
Ordinary
Sale
200
3675
Ordinary
Sale
200
3679
Ordinary
Sale
200
3679
Ordinary
Sale
300
3677
Ordinary
Sale
600
3678
Ordinary
Sale
200
3678
Ordinary
Sale
300
3678
Ordinary
Sale
300
3713
Ordinary
Sale
100
3719
Ordinary
Sale
100
3666
Ordinary
Sale
100
3668
Ordinary
Sale
100
3667
Ordinary
Sale
100
3666
Ordinary
Sale
100
3700
Ordinary
Sale
100
3745
Ordinary
Sale
100
3732
Ordinary
Sale
100
3740
Ordinary
Sale
100
3739
Ordinary
Sale
100
3728
Ordinary
Sale
100
3716
Ordinary
Sale
100
3742
Ordinary
Sale
100
3671
Ordinary
Sale
100
3671
Ordinary
Sale
100
3716
Ordinary
Sale
100
3742
Ordinary
Sale
100
3729
Ordinary
Sale
100
3734
Ordinary
Sale
100
3717
Ordinary
Sale
1,100
3673
Ordinary
Sale
100
3731
Ordinary
Sale
100
3746
Ordinary
Sale
100
3668
Ordinary
Sale
200
3745
Ordinary
Sale
100
3746
Ordinary
Sale
100
3668
Ordinary
Sale
100
3708
Ordinary
Sale
100
3711
Ordinary
Sale
100
3673
Ordinary
Sale
200
3737
Ordinary
Sale
100
3737
Ordinary
Sale
100
3742
Ordinary
Sale
100
3705
Ordinary
Sale
100
3675
Ordinary
Sale
100
3743
Ordinary
Sale
100
3730
Ordinary
Sale
100
3731
Ordinary
Sale
100
3727
Ordinary
Sale
100
3711
Ordinary
Sale
100
3678
Ordinary
Sale
100
3735
Ordinary
Sale
100
3679
Ordinary
Sale
100
3740
Ordinary
Sale
100
3727
Ordinary
Sale
100
3743
Ordinary
Sale
100
3747
Ordinary
Sale
100
3715
Ordinary
Sale
100
3727
Ordinary
Sale
100
3676
Ordinary
Sale
100
3719
Ordinary
Sale
100
3746
Ordinary
Sale
100
3715
Ordinary
Sale
100
3744
Ordinary
Sale
100
3740
Ordinary
Sale
100
3672
Ordinary
Sale
100
3714
Ordinary
Sale
100
3676
Ordinary
Sale
100
3717
Ordinary
Sale
100
3723
Ordinary
Sale
100
3739
Ordinary
Sale
100
3727
Ordinary
Sale
100
3738
Ordinary
Sale
100
3744
Ordinary
Sale
100
3745
Ordinary
Sale
100
3736
Ordinary
Sale
100
3677
Ordinary
Sale
100
3710
Ordinary
Sale
100
3676
Ordinary
Sale
100
3671
Ordinary
Sale
100
3744
Ordinary
Sale
100
3723
Ordinary
Sale
100
3711
Ordinary
Sale
100
3670
Ordinary
Sale
100
3743
Ordinary
Sale
100
3707
Ordinary
Sale
100
3672
Ordinary
Sale
100
3708
Ordinary
Sale
100
3671
Ordinary
Sale
100
3704
Ordinary
Sale
100
3717
Ordinary
Sale
100
3743
Ordinary
Sale
100
3676
Ordinary
Sale
100
3744
Ordinary
Sale
100
3729
Ordinary
Sale
100
3672
Ordinary
Sale
100
3741
Ordinary
Sale
100
3721
Ordinary
Sale
100
3674
Ordinary
Sale
100
3742
Ordinary
Sale
100
3717
Ordinary
Sale
100
3745
Ordinary
Sale
100
3673
Ordinary
Sale
100
3714
Ordinary
Sale
100
3710
Ordinary
Sale
100
3746
Ordinary
Sale
100
3671
Ordinary
Sale
100
3742
Ordinary
Sale
100
3673
Ordinary
Sale
100
3739
Ordinary
Sale
100
3708
Ordinary
Sale
100
3672
Ordinary
Sale
100
3743
Ordinary
Sale
100
3711
Ordinary
Sale
100
3676
Ordinary
Sale
100
3678
Ordinary
Sale
100
3738
Ordinary
Sale
100
3715
Ordinary
Sale
100
3724
Ordinary
Sale
100
3710
Ordinary
Sale
100
3729
Ordinary
Sale
100
3745
Ordinary
Sale
100
3746
Ordinary
Sale
100
3681
Ordinary
Sale
100
3681
Ordinary
Sale
100
3713
Ordinary
Sale
100
3732
Ordinary
Sale
100
3739
Ordinary
Sale
100
3740
Ordinary
Sale
100
3711
Ordinary
Sale
100
3675
Ordinary
Sale
100
3676
Ordinary
Sale
100
3731
Ordinary
Sale
100
3725
Ordinary
Sale
100
3742
Ordinary
Sale
100
3742
Ordinary
Sale
100
3677
Ordinary
Sale
100
3715
Ordinary
Sale
100
3744
Ordinary
Sale
100
3729
Ordinary
Sale
100
3687
Ordinary
Sale
100
3729
Ordinary
Sale
100
3685
Ordinary
Sale
100
3741
Ordinary
Sale
100
3680
Ordinary
Sale
100
3719
Ordinary
Sale
100
3720
Ordinary
Sale
100
3681
Ordinary
Sale
100
3727
Ordinary
Sale
100
3738
Ordinary
Sale
100
3731
Ordinary
Sale
100
3747
Ordinary
Sale
100
3718
Ordinary
Sale
100
3743
Ordinary
Sale
100
3732
Ordinary
Sale
100
3679
Ordinary
Sale
100
3686
Ordinary
Sale
100
3740
Ordinary
Sale
100
3720
Ordinary
Sale
100
3717
Ordinary
Sale
100
3719
Ordinary
Sale
100
3719
Ordinary
Sale
100
3738
Ordinary
Sale
100
3743
Ordinary
Sale
100
3680
Ordinary
Sale
100
3728
Ordinary
Sale
100
3725
Ordinary
Sale
100
3684
Ordinary
Sale
100
3728
Ordinary
Sale
100
3728
Ordinary
Sale
100
3741
Ordinary
Sale
100
3715
Ordinary
Sale
100
3682
Ordinary
Sale
100
3737
Ordinary
Sale
100
3740
Ordinary
Sale
100
3741
Ordinary
Sale
100
3721
Ordinary
Sale
100
3740
Ordinary
Sale
100
3711
Ordinary
Sale
100
3719
Ordinary
Sale
100
3740
Ordinary
Sale
100
3741
Ordinary
Sale
100
3714
Ordinary
Sale
100
3709
Ordinary
Sale
100
3743
Ordinary
Sale
100
3731
Ordinary
Sale
100
3712
Ordinary
Sale
100
3680
Ordinary
Sale
100
3738
Ordinary
Sale
100
3731
Ordinary
Sale
100
3720
Ordinary
Sale
100
3713
Ordinary
Sale
100
3710
Ordinary
Sale
100
3737
Ordinary
Sale
100
3746
Ordinary
Sale
100
3718
Ordinary
Sale
100
3737
Ordinary
Sale
100
3747
Ordinary
Sale
100
3680
Ordinary
Sale
100
3744
Ordinary
Sale
100
3728
Ordinary
Sale
100
3679
Ordinary
Sale
100
3745
Ordinary
Sale
100
3746
Ordinary
Sale
100
3740
Ordinary
Sale
100
3721
Ordinary
Sale
100
3717
Ordinary
Sale
100
3674
Ordinary
Sale
100
3738
Ordinary
Sale
100
3730
Ordinary
Sale
100
3676
Ordinary
Sale
2,300
3718
Ordinary
Sale
100
3717
Ordinary
Sale
100
3730
Ordinary
Sale
100
3745
Ordinary
Sale
100
3739
Ordinary
Sale
100
3745
Ordinary
Sale
100
3740
Ordinary
Sale
100
3743
Ordinary
Sale
100
3731
Ordinary
Sale
100
3722
Ordinary
Sale
100
3718
Ordinary
Sale
100
3747
Ordinary
Sale
100
3748
Ordinary
Sale
100
3718
Ordinary
Sale
100
3708
Ordinary
Sale
100
3738
Ordinary
Sale
100
3747
Ordinary
Sale
100
3675
Ordinary
Sale
100
3741
Ordinary
Sale
100
3741
Ordinary
Sale
100
3741
Ordinary
Sale
100
3671
Ordinary
Sale
3,000
3717
Ordinary
Sale
600
3677
Ordinary
Sale
200
3674
Ordinary
Sale
600
3678
Ordinary
Sale
300
3678
Ordinary
Sale
700
3677
Ordinary
Sale
2,600
3747
Ordinary
Sale
500
3682
Ordinary
Sale
100
3682
Ordinary
Sale
800
3682
Ordinary
Sale
2,600
3737
Ordinary
Sale
1,500
3681
Ordinary
Sale
2,600
3730
Ordinary
Sale
2,600
3740
Ordinary
Sale
5,200
3748
Ordinary
Sale
2,100
3718
Ordinary
Sale
2,400
3746
Ordinary
Sale
900
3709
Ordinary
Sale
100
3679
Ordinary
Sale
400
3676
Ordinary
Sale
400
3678
Ordinary
Sale
400
3677
Ordinary
Sale
1,100
3714
Ordinary
Sale
1,100
3741
Ordinary
Sale
300
3676
Ordinary
Sale
100
3707
Ordinary
Sale
1,100
3672
Ordinary
Sale
400
3672
Ordinary
Sale
1,100
3672
Ordinary
Sale
600
3711
Ordinary
Sale
400
3676
Ordinary
Sale
900
3677
Ordinary
Sale
2,200
3679
Ordinary
Sale
200
3703
Ordinary
Sale
300
3710
Ordinary
Sale
1,100
3742
Ordinary
Sale
1,100
3680
Ordinary
Sale
1,100
3748
Ordinary
Sale
1,100
3707
Ordinary
Sale
1,100
3674
Ordinary
Sale
100
3731
Ordinary
Sale
1,000
3718
Ordinary
Sale
600
3720
Ordinary
Sale
600
3720
Ordinary
Sale
100
3702
Ordinary
Sale
800
3709
Ordinary
Sale
800
3699
Ordinary
Sale
700
3708
Ordinary
Sale
600
3721
Ordinary
Sale
100
3681.5
Ordinary
Sale
100
3680.5
Ordinary
Sale
100
3701.5
Ordinary
Sale
33,560
3681.167975
Ordinary
Sale
24,498
3690.109192
Ordinary
Sale
83,900
3714.792526
Total Purchases
277,800
Total Sales
325,458
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
Ordinary
CFD
Increasing a long position
21,100
3681.168009
Ordinary
CFD
Increasing a long position
12,000
3681.168009
Ordinary
CFD
Increasing a long position
460
3681.168009
Ordinary
CFD
Increasing a long position
398
3690.109192
Ordinary
CFD
Increasing a long position
15,400
3690.109192
Ordinary
CFD
Increasing a long position
8,700
3690.109192
Ordinary
CFD
Increasing a long position
9,200
3712.233663
Ordinary
CFD
Increasing a long position
300
3712.233663
Ordinary
CFD
Increasing a long position
16,300
3712.233663
Ordinary
CFD
Increasing a long position
33,794
3714.792526
Ordinary
CFD
Increasing a long position
15,638
3714.792526
Ordinary
CFD
Increasing a long position
32,060
3714.792526
Ordinary
CFD
Increasing a long position
2,408
3714.792526
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit JPY
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
13/12/2018
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
OTC put-option
Sale
15,700
4707
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,000
5075.10
European options
14/12/2018
Ordinary
OTC put-option
Sale
29,600
5073.65
European options
14/12/2018
Ordinary
OTC put-option
Sale
15,500
4491.40
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,700
4533.90
European options
14/12/2018
Ordinary
Listed call-option
Sale
125,000
5500
European options
13/06/2019
Ordinary
OTC call-option
Sale
131,000
4,600
European options
13/12/2018
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETGGGAPPUPRGUW
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement